JP6973779B2 - Composition for detecting air leaks during lung surgery - Google Patents
Composition for detecting air leaks during lung surgery Download PDFInfo
- Publication number
- JP6973779B2 JP6973779B2 JP2017133820A JP2017133820A JP6973779B2 JP 6973779 B2 JP6973779 B2 JP 6973779B2 JP 2017133820 A JP2017133820 A JP 2017133820A JP 2017133820 A JP2017133820 A JP 2017133820A JP 6973779 B2 JP6973779 B2 JP 6973779B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- lung
- present
- marked
- air
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Materials For Medical Uses (AREA)
- Endoscopes (AREA)
Description
本発明は、肺手術時の空気漏れ検出用組成物に関する。 The present invention relates to a composition for detecting air leaks during lung surgery.
手術による肺切除後には、残す肺からの空気の漏れがないかを確認することが重要である。 After surgical lung resection, it is important to check for air leaks from the remaining lungs.
現状では、生理食塩水を胸腔内に充填し、術側肺に空気を送り込み加圧し膨張させて胸腔外より目視で空気漏れの箇所が確認されている。一方、現在、肺切除の主流となっている内視鏡手術においては、肺を虚脱させて得られた胸腔内のワーキングスペースに体外より挿入したスコープで内部を観察して手術を行うため、胸腔内に生理食塩水を充満させ肺を加圧するとワーキングスペースが消失し肺表面の観察は難しくなる。しかしながら、現在はこの方法以外での空気漏れの有無の確認あるいは空気漏れ箇所の同定は行われていない。 At present, the thoracic cavity is filled with physiological saline, and air is sent to the operated lung to pressurize and inflate, and the location of air leakage is visually confirmed from outside the thoracic cavity. On the other hand, in endoscopic surgery, which is currently the mainstream of lung resection, the thoracic cavity is operated by observing the inside with a scope inserted from outside the body into the working space in the thoracic cavity obtained by collapsing the lung. When the inside is filled with physiological saline and the lungs are pressurized, the working space disappears and it becomes difficult to observe the lung surface. However, at present, the presence or absence of an air leak or the identification of an air leak location has not been performed by any method other than this method.
そのため、創を閉鎖してドレナージを行って初めて空気漏れの存在がわかる例があり、ドレーンの留置期間が長くなり入院期間の延長や患者QOLの低下をまねいたり、空気漏れの量が多ければ再手術を要するケースもある。 Therefore, there are cases where the existence of air leaks can be detected only after the wound is closed and drainage is performed. In some cases, surgery is required.
結果として、より確実な空気漏れの同定方法の開発が求められている。 As a result, there is a need to develop a more reliable method for identifying air leaks.
微生物により産生される界面活性剤であるバイオサーファクタントは、化学合成により得られる界面活性剤と同等の性能を示し、且つ生分解性が高く低毒性であるため、安全性が高く環境負荷が低い界面活性剤である。その中でも、植物油(パーム油)と糖を原料として酵母による発酵により生産される天然糖脂質であるソホロースリピッドは、糖質(ソホロース)と脂肪酸(主にオレイン酸)からなり、比較的安価な原料から生産され、且つ大量生産も可能である。 Biosurfactants, which are surfactants produced by microorganisms, show the same performance as surfactants obtained by chemical synthesis, and because they are highly biodegradable and low in toxicity, they are safe and have a low environmental load. It is an activator. Among them, sophorose lipid, which is a natural glycolipid produced by fermentation with yeast using vegetable oil (palm oil) and sugar as raw materials, consists of sugar (sophorose) and fatty acid (mainly oleic acid) and is relatively inexpensive. It is produced from raw materials and can be mass-produced.
ソホロースリピッドに関しては、カンジダ属酵母を用いた高収量且つ高収率でソホロースリピッドが生成される発酵生産法(特許文献1)、有機溶媒を用いることなく、培養終了液から液体及び固形成分を除去し、高濃度のソホロースリピッドを得る方法(特許文献2)などが報告されている。 Regarding sophorose lipid, a fermentation production method using Candida yeast to produce sophorose lipid in high yield and high yield (Patent Document 1), liquid and solid components from the culture termination liquid without using an organic solvent. (Patent Document 2) and the like have been reported as a method for obtaining a high-concentration solvent lipid by removing the yeast.
本発明は、内視鏡手術において、より確実に空気漏れの有無の確認及び空気漏れ箇所の同定が可能である、肺手術時の空気漏れ検出用組成物を提供することを目的とする。 An object of the present invention is to provide a composition for detecting an air leak during lung surgery, which can more reliably confirm the presence or absence of an air leak and identify an air leak location in endoscopic surgery.
本発明者は、上記目的を達成すべく鋭意研究を重ねた結果、界面活性剤を肺表面に塗布した状態で肺を加圧し膨張させ、しばらくしてから再度肺を虚脱させ、胸腔内をスコープで観察し、泡立つ箇所を探すことで、空気漏れの有無の確認及び空気漏れ箇所の同定が可能になるという知見を得た。 As a result of diligent research to achieve the above object, the present inventor pressurizes and inflates the lung with a surfactant applied to the surface of the lung, and after a while, causes the lung to collapse again and scopes the inside of the thoracic cavity. We obtained the finding that it is possible to confirm the presence or absence of air leaks and identify the location of air leaks by observing and searching for foaming spots.
本発明は、これら知見に基づき、更に検討を重ねて完成されたものであり、次の肺手術時の空気漏れ検出用組成物を提供するものである。 The present invention has been completed by further studying based on these findings, and provides a composition for detecting an air leak at the time of the next lung surgery.
項1.界面活性剤を含む肺手術時の空気漏れ検出用組成物。
項2.前記界面活性剤がソホロースリピッドを含む、項1に記載の組成物。
項3.更に着色剤を含む、項1又は2に記載の組成物。
項4.内視鏡手術において使用される、項1〜3のいずれか一項に記載の組成物。
Item 1. A composition for detecting air leaks during lung surgery containing a surfactant.
Item 2. Item 2. The composition according to Item 1, wherein the surfactant comprises sophorose lipid.
Item 3. Item 2. The composition according to Item 1 or 2, further comprising a colorant.
Item 4. Item 6. The composition according to any one of Items 1 to 3, which is used in endoscopic surgery.
本発明の空気漏れ検出用組成物によれば、内視鏡手術において、肺の加圧中にワーキングスペースの無くなった胸腔内をスコープで観察する必要が無く、より確実に空気漏れの有無の確認及び空気漏れ箇所の同定が可能である。 According to the composition for detecting air leakage of the present invention, in endoscopic surgery, it is not necessary to observe the inside of the thoracic cavity where the working space has disappeared during pressurization of the lung with a scope, and it is possible to more reliably confirm the presence or absence of air leakage. And it is possible to identify the location of the air leak.
また、本発明の空気漏れ検出用組成物に着色剤を含ませることで、視認性を向上させることができる。 Further, by including a colorant in the composition for detecting air leakage of the present invention, visibility can be improved.
本発明の空気漏れ検出用組成物の中でも、特にソホロースリピッドを含むものは、肺表面での伸びと留まりが良好であり、容易に塗布及び除去することができる上、起泡性にも優れる。 Among the compositions for detecting air leaks of the present invention, those containing sophorose lipid have good elongation and retention on the lung surface, can be easily applied and removed, and have excellent foaming properties. ..
以下、本発明について詳細に説明する。 Hereinafter, the present invention will be described in detail.
なお、本明細書において「含む(comprise)」とは、「本質的にからなる(essentially consist of)」という意味と、「のみからなる(consist of)」という意味をも包含する。 It should be noted that, in the present specification, "comprise" also includes the meaning of "essentially consist of" and the meaning of "consist of".
本発明の肺手術時の空気漏れ検出用組成物は、界面活性剤を含むことを特徴とする。 The composition for detecting air leakage during lung surgery of the present invention is characterized by containing a surfactant.
界面活性剤としては、非イオン性界面活性剤、陽イオン性界面活性剤、両性界面活性剤、陰イオン性界面活性剤のいずれも特に制限なく使用することができ、中でも人体に有害でなく、医薬品、医薬部外品、化粧品、食品などとして使用可能なものが好ましい。 As the surfactant, any of nonionic surfactant, cationic surfactant, amphoteric surfactant, and anionic surfactant can be used without particular limitation, and among them, it is not harmful to the human body and is not harmful to the human body. Those that can be used as pharmaceuticals, non-pharmaceutical products, cosmetics, foods, etc. are preferable.
非イオン性界面活性剤としては、例えば、ポリオキシエチレン(POE)−ポリオキシプロピレン(POP)ブロックコポリマー(ポロクサマーなど)、エチレンジアミンのPOE-POPブロックコポリマー付加物、POEソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル類、POEヒマシ油、POEアルキルフェニルエーテル、POEアルキルエーテル、POE・POPアルキルエーテル、ソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、アルキルポリグリコシド、プロピレングリコール脂肪酸エステル、モノステアリン酸ポリエチレングリコール、グリセリン脂肪酸エステル、ソホロースリピッドなどが挙げられる。 Nonionic surfactants include, for example, polyoxyethylene (POE) -polyoxypropylene (POP) block copolymers (such as Poroxummer), POE-POP block copolymer adducts of ethylenediamine, POE sorbitan fatty acid esters, propylene glycol fatty acid esters. Kind, POE castor oil, POE alkylphenyl ether, POE alkyl ether, POE / POP alkyl ether, sorbitan fatty acid ester, sucrose fatty acid ester, alkyl polyglycoside, propylene glycol fatty acid ester, monostearate polyethylene glycol, glycerin fatty acid ester, soho Examples include loin lipid.
両性界面活性剤としては、例えば、卵黄レシチン、大豆レシチン等のレシチン、アルキルジアミノエチルグリシン又はその塩などが挙げられる。 Examples of the amphoteric tenside include lecithin such as egg yolk lecithin and soybean lecithin, alkyldiaminoethylglycine or a salt thereof.
陽イオン性界面活性剤としては、特に制限なく使用することができ、例えば、塩化ベンゼトニウム、塩化ベンザルコニウムなどが挙げられる。 The cationic surfactant can be used without particular limitation, and examples thereof include benzethonium chloride and benzalkonium chloride.
陰イオン性界面活性剤としては、特に制限なく使用することができ、例えば、ポリオキシエチレンアルキル硫酸塩、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、脂肪族α−スルホメチルエステル、α−オレフィンスルホン酸などが挙げられる。 The anionic surfactant can be used without particular limitation, and for example, polyoxyethylene alkyl sulfate, alkyl sulfate, alkylbenzene sulfonate, aliphatic α-sulfomethyl ester, α-olefin sulfonic acid and the like can be used. Can be mentioned.
界面活性剤の中でも、安全性が高いバイオサーファクタントが好ましく、ソホロースリピッドが特に好ましい。ソホロースリピッドは、後述する実施例で示すように、肺手術時の空気漏れの検出に特に好適に使用できる。ソホロースリピッドは、肺表面での伸びと留まりが良好であり、容易に塗布及び除去することができる上、起泡性にも優れている。 Among the surfactants, biosurfactants with high safety are preferable, and sophorose lipid is particularly preferable. Sophorose lipids can be particularly suitably used for detecting air leaks during lung surgery, as shown in Examples described later. Sophorose lipid has good elongation and retention on the lung surface, can be easily applied and removed, and has excellent foaming property.
ソホロースリピッドは、一般的にソホロース又はヒドロキシル基が一部アセチル化したソホロースと、ヒドロキシ脂肪酸とからなる糖脂質である。ソホロースリピッドの構造は、特開2003-9896号公報、特開2016-160244号公報などに記載されている。ソホロースとは、β1→2結合した2分子のブドウ糖からなる糖である。ヒドロキシ脂肪酸とは、ヒドロキシル基を有する脂肪酸である。また、ソホロースリピッドは、ヒドロキシ脂肪酸のカルボキシル基が遊離した酸型と、分子内のソホロースが結合したラクトン型とに大別される。ある種の酵母の発酵によって得られるソホロースリピッドは、通常、酸型とラクトン型の混合物であり、30種以上の構造同族体の集合体として得られる。 Sophorose lipid is generally a glycolipid composed of sophorose or sophorose having a partially acetylated hydroxyl group and a hydroxy fatty acid. The structure of the sophorose lipid is described in JP-A-2003-9896, JP-A-2016-160244 and the like. Sophorose is a sugar consisting of two molecules of glucose linked from β1 to 2. Hydroxy fatty acids are fatty acids having a hydroxyl group. Further, the sophorose lipid is roughly classified into an acid type in which the carboxyl group of the hydroxy fatty acid is liberated and a lactone type in which sophorose in the molecule is bound. Sophorose lipids obtained by fermentation of certain yeasts are usually a mixture of acid and lactone types and are obtained as an aggregate of more than 30 structural homologues.
ソホロースリピッドとしては、例えば、ソホロリピッド(登録商標)(サラヤ株式会社)などが市販品として存在する。 As the sophorose lipid, for example, sophorolipid (registered trademark) (Salaya Co., Ltd.) exists as a commercially available product.
本発明において界面活性剤は単独で又は2種以上組み合わせて使用することができる。 In the present invention, the surfactant can be used alone or in combination of two or more.
本発明の空気漏れ検出用組成物における界面活性剤の含量は、組成物全量中、通常0.001〜100容量%、好ましくは0.01〜75容量%、より好ましくは0.1〜50容量%の範囲から適宜選択することができる。 The content of the surfactant in the composition for detecting air leakage of the present invention is appropriately selected from the range of usually 0.001 to 100% by volume, preferably 0.01 to 75% by volume, and more preferably 0.1 to 50% by volume in the total amount of the composition. can do.
本発明の空気漏れ検出用組成物には、界面活性剤以外に、通常、溶媒が含まれ、溶媒としては水又は水と有機溶媒の含水有機溶媒が挙げられる。当該有機溶媒としては、水と自由に混和可能なものが好ましく、そのようなものとしては、メタノール、エタノール等のアルコール、アセトン等のケトン、酢酸等の有機酸などが挙げられる。 The composition for detecting an air leak of the present invention usually contains a solvent in addition to the surfactant, and examples of the solvent include water or a water-containing organic solvent containing water and an organic solvent. The organic solvent is preferably one that is freely miscible with water, and examples thereof include alcohols such as methanol and ethanol, ketones such as acetone, and organic acids such as acetic acid.
本発明の空気漏れ検出用組成物には、好ましくは、着色剤が含まれる。着色剤が含まれることで、視認性が向上し、空気漏れの有無の確認及び空気漏れ箇所の同定をより確実に行えるようになる。 The composition for detecting air leakage of the present invention preferably contains a colorant. By including the colorant, the visibility is improved, and it becomes possible to confirm the presence or absence of an air leak and identify the location of the air leak more reliably.
着色剤(色素)としては、本発明の空気漏れ検出用組成物を着色できる限り特に制限されず、いずれの着色剤も使用でき、中でも人体に有害でなく、医薬品、医薬部外品、化粧品、食品などとして使用可能なものが好ましい。 The colorant (dye) is not particularly limited as long as the composition for detecting air leakage of the present invention can be colored, and any colorant can be used, and among them, it is not harmful to the human body, and is a pharmaceutical product, quasi-drug, cosmetic product, etc. Those that can be used as foods are preferable.
着色剤としては、例えば、食用黄色4号、5号、食用赤色3号、102号、食用青色1号、2号、食用緑色3号、黄色三二酸化鉄、赤色三二酸化鉄、黒色酸化鉄などが挙げられる。着色剤としては、視認性に優れているため、青色及び緑色のものが好ましい。 Examples of colorants include edible yellow Nos. 4 and 5, edible red Nos. 3 and 102, edible blue Nos. 1 and 2, edible green No. 3, yellow tricarbonate, red tricarbonate, and black iron oxide. Can be mentioned. As the colorant, blue and green colorants are preferable because they have excellent visibility.
本発明の空気漏れ検出用組成物における着色剤の含量は、組成物全量中、通常0.00001〜1w/v%、好ましくは0.0001〜0.1w/v%、より好ましくは0.001〜0.01w/v%の範囲から適宜選択することができる。 The content of the colorant in the composition for detecting air leakage of the present invention is usually 0.00001 to 1w / v%, preferably 0.0001 to 0.1w / v%, and more preferably 0.001 to 0.01w / v% in the total amount of the composition. It can be appropriately selected from the range.
本発明の空気漏れ検出用組成物には、界面活性剤、溶媒及び着色剤以外にも、必要に応じて、懸濁化剤、増粘剤、抗酸化剤、緩衝剤、pH調節剤、保存剤、防腐剤等の薬学的に許容される成分を適宜配合することができる。 In addition to the surfactant, solvent and colorant, the composition for detecting air leakage of the present invention includes, if necessary, a suspending agent, a thickener, an antioxidant, a buffer, a pH adjuster, and a storage agent. Pharmaceutically acceptable ingredients such as agents and preservatives can be appropriately blended.
本発明の空気漏れ検出用組成物のpHは、通常pH4〜10、好ましくはpH5〜9である。 The pH of the composition for detecting an air leak of the present invention is usually pH 4 to 10, preferably pH 5 to 9.
本発明の空気漏れ検出用組成物は、濃縮形態とすることもでき、その場合は、使用時に適切な濃度に適宜希釈して使用することができる。 The composition for detecting an air leak of the present invention may be in a concentrated form, and in that case, it can be appropriately diluted to an appropriate concentration at the time of use.
本発明の空気漏れ検出用組成物を肺表面に塗布した状態で肺を加圧し膨張させ、しばらくしてから再度肺を虚脱させ、胸腔内を観察し、泡立つ箇所を探すことで、空気漏れの有無の確認及び空気漏れ箇所の同定を行うことができる。また、空気漏れの有無の確認を行った後には、必要により、本発明の組成物を生理食塩水等で洗浄し除去する。 The composition for detecting air leaks of the present invention is applied to the surface of the lungs, and the lungs are pressurized and inflated. It is possible to confirm the presence or absence and identify the location of air leakage. Further, after confirming the presence or absence of air leakage, if necessary, the composition of the present invention is washed with physiological saline or the like to remove it.
本発明の空気漏れ検出用組成物は、肺手術時に使用され、ここで肺の手術の種類としては特に制限されず、残す肺から空気漏れが生じる可能性がある肺を切除する手術に好適に使用できる。本発明の空気漏れ検出用組成物は、特に内視鏡手術において好適に使用される。これは、内視鏡手術では、肺を加圧するとワーキングスペースが消失し肺表面の観察は難しくなるが、本発明の組成物を用いることで、肺を虚脱させてから、胸腔内をスコープで観察することでも、空気漏れの有無の確認及び空気漏れ箇所の同定が可能となるからである。 The composition for detecting air leakage of the present invention is used in lung surgery, and the type of lung surgery is not particularly limited, and is suitable for surgery to remove a lung in which air leakage may occur from the remaining lung. Can be used. The composition for detecting air leakage of the present invention is particularly preferably used in endoscopic surgery. This is because in endoscopic surgery, when the lungs are pressurized, the working space disappears and it becomes difficult to observe the lung surface, but by using the composition of the present invention, the lungs are collapsed and then the inside of the thoracic cavity is scoped. This is because it is possible to confirm the presence or absence of an air leak and identify the location of the air leak by observing.
本発明の空気漏れ検出用組成物を肺に塗布する方法は、特に制限されず、公知の手法を適宜使用することができる。 The method for applying the composition for detecting an air leak of the present invention to the lungs is not particularly limited, and a known method can be appropriately used.
本発明の空気漏れ検出用組成物を塗布する量は、肺の大きさなどの種々の条件に応じて適宜決定することができる。 The amount of the composition for detecting air leakage of the present invention to be applied can be appropriately determined according to various conditions such as the size of lungs.
本発明の空気漏れ検出用組成物は、ヒトを含む哺乳動物に対して投与される。 The composition for detecting air leaks of the present invention is administered to mammals including humans.
本発明の空気漏れ検出用組成物は、内視鏡手術において、肺の加圧中にワーキングスペースの無くなった胸腔内をスコープで観察する必要が無く、より確実に空気漏れの有無の確認及び空気漏れ箇所の同定が行えるようになる。 The composition for detecting air leakage of the present invention does not require a scope to observe the inside of the thoracic cavity where the working space has disappeared during pressurization of the lung in endoscopic surgery, and more reliably confirms the presence or absence of air leakage and air. You will be able to identify the leak location.
このように、本発明の組成物を用いることで、より確実に空気漏れの有無の確認が行えるため、入院期間の延長、患者のQOLの低下、再手術などのリスクを低下できることが期待される。 As described above, by using the composition of the present invention, the presence or absence of air leakage can be confirmed more reliably, and it is expected that the risk of extension of hospitalization period, deterioration of patient's QOL, reoperation, etc. can be reduced. ..
また、本発明の空気漏れ検出用組成物に着色剤を含ませれば、視認性を向上させることができ、更に確実に空気漏れの有無の確認及び空気漏れ箇所の同定が行えるようになる。 Further, if the composition for detecting an air leak of the present invention contains a colorant, the visibility can be improved, and the presence or absence of an air leak can be confirmed and the location of the air leak can be identified more reliably.
以下、本発明を更に詳しく説明するため実施例を挙げる。しかし、本発明はこれら実施例等になんら限定されるものではない。なお、本実施例中の%は、特に断らない限りw/v%を示すものとする。 Hereinafter, examples will be given to explain the present invention in more detail. However, the present invention is not limited to these examples and the like. In addition,% in this Example shall indicate w / v% unless otherwise specified.
参考例1:豚肺による肺からの空気漏れモデルの作製
(1) 研究用動物臓器として購入した豚肺を用いて検討を行った。豚気管内に内径7.5 mmカフ付き気管チューブを挿入固定し、加圧バッグに接続し豚肺を加圧し膨張させた。豚肺を水中において加圧し、空気漏れがないことを確認した。
Reference example 1: Creating a model of air leakage from the lungs using pig lungs
(1) A study was conducted using pig lungs purchased as animal organs for research. A tracheal tube with an inner diameter of 7.5 mm was inserted and fixed in the pig trachea, connected to a pressure bag, and the pig lung was pressurized and inflated. The pig lung was pressurized in water, and it was confirmed that there was no air leakage.
(2) 豚肺を水中から取り出し、肺表面をメスで2〜3 mm切開し、再び水中において加圧し、切開部から空気漏れがあることを確認した。 (2) The pig lung was taken out of the water, the surface of the lung was incised by a scalpel for 2 to 3 mm, and the pressure was applied again in the water, and it was confirmed that there was an air leak from the incision.
試験例1:界面活性剤の肺表面への塗布と起泡性の確認
(1) ソホロースリピッド含有の市販された洗剤(ハッピーエレファント、サラヤ株式会社)、ソホロースリピッドを含まない市販された洗剤(哺乳びん野菜洗い、ピジョン株式会社)、及び手術時に使用可能なレンズ曇り止め剤(クラリファイ、コヴィディエン社)の3剤をそれぞれ精製水で希釈し、下記の通りに界面活性剤の希釈液(1倍、2倍、5倍、10倍、20倍)を作製した。
Test Example 1: Application of surfactant to lung surface and confirmation of foaming property
(1) Commercially available detergent containing sophorose lipid (Happy Elephant, Saraya Co., Ltd.), commercially available detergent not containing sophorose lipid (baby bottle vegetable washing, Pigeon Co., Ltd.), and lens fogging that can be used during surgery. The three anti-fog agents (Clarify and Covidien) were diluted with purified water to prepare a diluted detergent solution (1 time, 2 times, 5 times, 10 times, 20 times) as shown below.
なお、ハッピーエレファントに含まれる界面活性剤は、アルキルエーテル硫酸エステルナトリウム、アルキルポリグリコシド及びソホロースリピッドであり、哺乳びん野菜洗いに含まれる界面活性剤は、ポリオキシエチレンソルビタン脂肪酸エステル、ショ糖脂肪酸エステル及びモノカプリル酸グリコセリルである。 The surfactants contained in Happy Elephant are alkyl ether sulfate sodium, alkyl polyglycoside and sophorose lipid, and the surfactants contained in baby bottle vegetable washing are polyoxyethylene sorbitan fatty acid ester and sucrose fatty acid. Esters and glycoceryl monocaprylate.
(2) 希釈した界面活性剤を参考例1で作製した虚脱した豚肺に塗布し、肺を加圧した。十分に加圧し肺を膨張させた後に加圧を解除し肺を虚脱させた。その際の各剤の塗布時の肺表面での延びの良さ、加圧時の起泡性、虚脱後の泡の空気漏れ部位への留まりを評価した。 (2) The diluted surfactant was applied to the collapsed pig lung prepared in Reference Example 1 to pressurize the lung. After sufficient pressure was applied to inflate the lungs, the pressure was released and the lungs collapsed. At that time, the goodness of spreading on the lung surface at the time of application of each agent, the foaming property at the time of pressurization, and the retention of foam after collapse at the air leak site were evaluated.
(3) 精製水100 mlで同部位を洗い流し、気泡の残存を確認した。 (3) The same site was rinsed with 100 ml of purified water, and residual air bubbles were confirmed.
塗布性、起泡性、残存性及び除去性について以下の基準に従ってそれぞれ評価した。結果を表2〜4に示す。
塗布性:溶液の肺表面での延びの良さについて、良好を○、やや不良を△、不良を×とした。
起泡性:泡立ちの良さについて、良好を○、やや不良を△、不良を×とした。
残存性:虚脱後の気泡の留まりについて、良好を○、やや不良を△、不良を×、評価不能を―とした。
除去性:洗い流し後の気泡の除去のしやすさについて良好を○、やや不良を△、不良を×とした。
The coatability, foaming property, residual property and removability were evaluated according to the following criteria. The results are shown in Tables 2-4.
Applyability: Regarding the good spread of the solution on the lung surface, good was marked with ◯, slightly poor was marked with Δ, and poor was marked with ×.
Foaming property: Regarding the goodness of foaming, good was evaluated as ◯, slightly defective was evaluated as Δ, and defective was evaluated as ×.
Residuality: Regarding the retention of air bubbles after collapse, good was evaluated as ◯, slightly defective as Δ, defective as ×, and unevaluable as −.
Removability: Good was marked with ◯, slightly defective was marked with Δ, and defective was marked with × for the ease of removing air bubbles after rinsing.
参考例2:塗布時の視認性の確認
すべての医薬品、医薬部外品、及び化粧品に使用可能な色素のうち、染着性が強くないとされる青色1号、緑色3号、黄色4号、及び黄色5号について、通常の医薬化粧品用途での使用濃度である0.001%及び0.01%濃度の色素水溶液を次のように作製した。各色素を0.01 g計りとり、精製水100 mlに溶解し、0.01%の色素水溶液を作製した。また、この色素水溶液を精製水で10倍希釈し0.001%の色素水溶液を作製した。作製した0.001%及び0.01%の色素水溶液を豚肺に塗布し、視認性を評価した。
Reference example 2: Confirmation of visibility at the time of application Of the pigments that can be used for all pharmaceutical products, quasi-drugs, and cosmetics, blue No. 1, green No. 3, and yellow No. 4, which are not considered to have strong dyeing properties, , And Yellow No. 5 were prepared as follows with 0.001% and 0.01% concentrations of dye aqueous solutions, which are the concentrations used in normal quasi-drug applications. Each dye was weighed in 0.01 g and dissolved in 100 ml of purified water to prepare a 0.01% aqueous dye solution. Moreover, this dye aqueous solution was diluted 10 times with purified water to prepare 0.001% dye aqueous solution. The prepared 0.001% and 0.01% dye aqueous solutions were applied to pig lungs, and the visibility was evaluated.
視認性及び除去性について以下の基準に従ってそれぞれ評価した。結果を表5及び6に示す。
視認性:良好を○、やや良好を△、不良を×とした。
色素除去性:色素水溶液を除去した後に色素沈着の無いものを○、わずかに沈着するものを△、沈着し除去不能なものを×とした。
Visibility and removability were evaluated according to the following criteria. The results are shown in Tables 5 and 6.
Visibility: Good was marked with ○, slightly good was marked with Δ, and poor was marked with ×.
Pigment removal property: Those without pigmentation after removing the aqueous dye solution were marked with ◯, those with slight deposition were marked with Δ, and those with deposition and irremovable were marked with x.
試験例2:色素含有界面活性剤を用いた起泡性の確認
試験例1で評価不能であったクラリファイを除き、ハッピーエレファント及び哺乳びん野菜洗いのそれぞれの希釈系に、参考例2で視認性不良であった黄色4号及び黄色5号を除き、青色1号、緑色3号をそれぞれ0.001%、0.01%濃度で加え着色した。具体的には、各色素を0.01 g計りとり、精製水10 mlに溶解し、0.1%の色素水溶液を作製した。当該色素水溶液を用いて、以下の通りに色素含有界面活性剤溶液を作製した。作製した0.001%及び0.01%の色素含有界面活性剤溶液を用いて、試験例1と同様の試験を行った。
Test Example 2: Confirmation of foaming property using a dye-containing surfactant Except for Clarify, which could not be evaluated in Test Example 1, visibility was obtained in Reference Example 2 for each dilution system of Happy Elephant and Baby Bottle Vegetable Wash. Except for the defective yellow No. 4 and yellow No. 5, blue No. 1 and green No. 3 were added at 0.001% and 0.01% concentrations, respectively, for coloring. Specifically, 0.01 g of each dye was weighed and dissolved in 10 ml of purified water to prepare a 0.1% aqueous dye solution. Using the dye aqueous solution, a dye-containing surfactant solution was prepared as follows. The same test as in Test Example 1 was carried out using the prepared 0.001% and 0.01% dye-containing surfactant solutions.
塗布性、起泡性、残存性、除去性、視認性、色素除去性について以下の基準に従ってそれぞれ評価した。結果を表9〜16に示す。
塗布性:溶液の肺表面での延びの良さについて、良好を○、やや不良を△、不良を×とした。
起泡性:泡立ちの良さについて、良好を○、やや不良を△、不良を×とした。
残存性:虚脱後の気泡の留まりについて、良好を○、やや不良を△、不良を×とした。
除去性:洗い流し後の気泡の除去のしやすさについて良好を○、やや不良を△、不良を×とした。
視認性:良好を○、やや良好を△、不良を×とした。
色素除去性:溶液を除去した後に色素沈着の無いものを○、わずかに沈着するものを△、沈着し除去不能なものを×とした。
The coatability, foaming property, residual property, removability, visibility, and dye removability were evaluated according to the following criteria. The results are shown in Tables 9-16.
Applyability: Regarding the good spread of the solution on the lung surface, good was marked with ◯, slightly poor was marked with Δ, and poor was marked with ×.
Foaming property: Regarding the goodness of foaming, good was evaluated as ◯, slightly defective was evaluated as Δ, and defective was evaluated as ×.
Residuality: Regarding the retention of air bubbles after collapse, good was evaluated as ◯, slightly defective was evaluated as Δ, and defective was evaluated as ×.
Removability: Good was marked with ◯, slightly defective was marked with Δ, and defective was marked with × for the ease of removing air bubbles after rinsing.
Visibility: Good was marked with ○, slightly good was marked with Δ, and poor was marked with ×.
Pigment removal property: Those without pigmentation after removing the solution were marked with ◯, those with slight deposition were marked with Δ, and those with deposition and irremovable were marked with x.
Claims (4)
The composition according to any one of claims 1 to 3, which is used in endoscopic surgery.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017133820A JP6973779B2 (en) | 2017-07-07 | 2017-07-07 | Composition for detecting air leaks during lung surgery |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017133820A JP6973779B2 (en) | 2017-07-07 | 2017-07-07 | Composition for detecting air leaks during lung surgery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019013517A JP2019013517A (en) | 2019-01-31 |
| JP6973779B2 true JP6973779B2 (en) | 2021-12-01 |
Family
ID=65356626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017133820A Active JP6973779B2 (en) | 2017-07-07 | 2017-07-07 | Composition for detecting air leaks during lung surgery |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6973779B2 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002045195A (en) * | 2000-08-04 | 2002-02-12 | Saraya Kk | Method for carrying out fermentation production of sophorose lipid |
| JP4714377B2 (en) * | 2001-06-29 | 2011-06-29 | サラヤ株式会社 | Purification method of sophorose lipid |
| US8181643B2 (en) * | 2006-04-28 | 2012-05-22 | Friedberg Joseph S | System and method for detection and repair of pulmonary air leaks |
| JP6034868B2 (en) * | 2011-09-02 | 2016-11-30 | 株式会社スリー・ディー・マトリックス | Amphipathic peptides for air leak obstruction in the chest |
| WO2015200582A1 (en) * | 2014-06-25 | 2015-12-30 | Neomend, Inc. | Pleural air leak test system |
-
2017
- 2017-07-07 JP JP2017133820A patent/JP6973779B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019013517A (en) | 2019-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2710522T3 (en) | Procedures and compositions for vein extraction and autotransplantation | |
| CN105431512B (en) | liquid cleaning composition | |
| US12175886B2 (en) | Fake blood for use in simulated surgical procedures | |
| KR20090064440A (en) | Colored or colorable foamable compositions and foams | |
| KR20130069542A (en) | Aqueous composition contained in container | |
| EP1902633A1 (en) | Method for preparing solubilized composition containing oil-soluble substance | |
| CN102526753A (en) | In-situ phase change gel slow release system taking phospholipid as substrate and preparation method thereof | |
| JP4790055B2 (en) | Vascular model for practicing stent graft insertion or aneurysm and suture surgery for aneurysms | |
| CN109414394A (en) | Topical composition containing ascorbic acid and/or its salt | |
| EP2818157A1 (en) | Lycopene-containing composition | |
| JP2019073558A (en) | Transparent cosmetic | |
| WO2013172187A1 (en) | Oil-based cleansing cosmetic | |
| JP6973779B2 (en) | Composition for detecting air leaks during lung surgery | |
| CN110184135A (en) | A kind of antibacterial dish washing liquid of propolis and preparation method thereof | |
| Damiyati et al. | In vitro anthelmintic activity of pineapple peel juice (Ananas comosus (L.) Merr.) against Paramphistomum sp. | |
| CN112741777B (en) | Preparation method of aloe arborescens extract-spearmint essential oil-chitosan-sodium alginate gel suitable for infants | |
| ES2435324B2 (en) | Procedure for separating the surfactants present from corn washing liquors and uses | |
| CN104586639A (en) | Arbutin liposome and preparation method thereof | |
| CN108192763A (en) | One seed pod wax remover and preparation method thereof | |
| ES2309735T3 (en) | VISCOELASTIC COMPOSITION THAT INCLUDES A NEW FREE RADICAL FAGOCITO; METHODS OF USE AND PACKAGING. | |
| JP6833307B2 (en) | Colored bactericidal formulation based on bispiridinium alkanes | |
| Delma et al. | Effects of supercritical carbon dioxide under conditions potentially conducive to sterilization on physicochemical characteristics of a liposome formulation containing apigenin | |
| ES2899330T3 (en) | Concentrate comprising at least one mannosyl erythritol lipid and at least one polyglycerol fatty acid ester | |
| JP4298866B2 (en) | Dechlorinating agent | |
| JP7787200B2 (en) | Composition for caring for keratinous materials |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200520 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210525 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210721 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210928 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211027 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6973779 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |